Business
Globus Medical develops musculoskeletal implants, surgical navigation and neuromodulation products.
Globus Medical converted integration and product demand into 17% growth, higher profit and nearly $600 million of free cash flow.
The read at a glance✓ Audited against SEC data
- Growth — Revenue grew 16.7%OK
- Profitability — Net income grew 422.3% to $537.868M from $102.984MOK
- Cash flow — Free cash flow grew 45.3% to $588.768M from $405.209MOK
- Margins — Operating margin expanded 974 bps to 16.33%OK
- Accounting — Strong musculoskeletal growth with merger integrationNote
- Insiders — 0 purchases and 13 salesWatch
Where the revenue comes from
Fiscal 2025, as GLOBUS MEDICAL INC reports it. History and quarterly detail are in the app.
- Musculoskeletal Solutions$2.8B
- Enabling Technologies$141.0M
Leadership changes
From GLOBUS MEDICAL INC's own filings, the day they're filed.
- John A. DeFord · member · departureeff. 2026-03-23
- Daniel J. Wolterman · Directors · appointmenteff. 2023-09-01
- Southeast Texas · departure
Latest filings
- 10-Q · Quarterly report2026-08-06
- 8-K · Company announcement2026-08-06
- 8-K · Company announcement2026-06-04
- 10-Q · Quarterly report2026-05-07
- 8-K · Company announcement2026-05-07
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about GLOBUS MEDICAL INC, every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.